17 related articles for article (PubMed ID: 10073138)
1. Aminosulfonylation of Alkenes for the Synthesis of β-Amino Sulfone Derivatives.
Zhang H; Zhao X; Yan R; Lin W
Org Lett; 2024 May; 26(20):4251-4256. PubMed ID: 38743879
[TBL] [Abstract][Full Text] [Related]
2. Studies on penam sulfones. I. Synthesis and beta-lactamase inhibitory activity of 2 beta-alkoxycarbonyl penicillanic acid sulfones.
Setti EL; Reddy NA; Phillips OA; Czajkowski DP; Atchison K; Atwal H; Micetich RG; Maiti SN; Kunugita C; Hyodo A
J Antibiot (Tokyo); 1996 Sep; 49(9):944-6. PubMed ID: 8931732
[No Abstract] [Full Text] [Related]
3. Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants).
Higashitani F; Nishida K; Hyodo A; Inoue M
J Antibiot (Tokyo); 1995 Sep; 48(9):1027-33. PubMed ID: 7592048
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam.
Kadima TA; Weiner JH
Antimicrob Agents Chemother; 1997 Oct; 41(10):2177-83. PubMed ID: 9333044
[TBL] [Abstract][Full Text] [Related]
5. Allyl and propargyl substituted penam sulfones as versatile intermediates toward the syntheses of new beta-lactamase inhibitors.
Sandanayaka VP; Feigelson GB; Prashad AS; Yang Y; Petersen PJ
Bioorg Med Chem Lett; 2001 Apr; 11(8):997-1000. PubMed ID: 11327608
[TBL] [Abstract][Full Text] [Related]
6. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Thomson KS; Moland ES
Antimicrob Agents Chemother; 2001 Dec; 45(12):3548-54. PubMed ID: 11709338
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2 beta-oxyimino and alkenylpenicillanic acid sulfone derivatives as beta-lactamase inhibitors.
Cho YS; Ha YJ; Kwon JS; Pae AN; Choi KI; Koh HY; Chang MH; Yoon CM; Lee GS
Arch Pharm (Weinheim); 1999 Jan; 332(1):7-12. PubMed ID: 10073138
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications.
Sutherland R
Infection; 1995; 23(4):191-200. PubMed ID: 8522374
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
